Add Row
Add Element
cropper
update
[Company Name]
Concierge Health Hub logo
update
Add Element
  • Home
  • Categories
    • Practice Mastery
    • Patient Connect
    • Financial Fitness
    • Tech Advantage
    • Marketing Mastery
    • Regulatory Radar
    • Wellness Wisdom
Add Row
Add Element
June 04.2025
3 Minutes Read

Understanding the Accuracy of Wearable Tech in Fitness Tracking: Insights for Health Practitioners

Understanding the Accuracy of Wearable Tech in Fitness Tracking: Insights for Health Practitioners


Wearable Technology: The Double-Edged Sword of Fitness Tracking

In an era where technology intertwines daily life, wearable devices such as the Apple Watch have become ubiquitous. Designed to help individuals monitor their fitness metrics, they promise insights into health and well-being. However, a recent study from the University of Mississippi reveals a pressing need for critical examination regarding their accuracy. With millions of people strongly relying on these devices, understanding their strengths and limitations is critical for practitioners who advise patients on fitness and health management.

The Research Behind the Numbers

Researchers Minsoo Kang and Ju-Pil Choe conducted a comprehensive meta-analysis of 56 studies comparing the Apple Watch to established reference tools, particularly analyzing its performance in key metrics like energy expenditure, heart rate, and step count. Their results are telling. While the devices demonstrate considerable accuracy with heart rates (mean absolute percent error at 4.43%) and step counts (8.17%), they struggle significantly with energy expenditure, obtaining a mean absolute percent error of 27.96%. This suggests that while these wearable devices can be beneficial for tracking basic fitness data, users should be cautious and not rely solely on their readings.

Understanding the Range of Accuracy

The study found that accuracy varied significantly based on various factors including age, the version of the Apple Watch, and the type of physical activity being performed. For example, younger users showed a tendency to receive more accurate data when engaging in aerobic activities like running, while older adults or those with existing health conditions may experience discrepancies.

Implications for Fitness Decision-Making

Incorporating this knowledge into practice can reshape how practitioners advise patients. Understanding that these devices may not always provide precise data is crucial—especially when individuals depend on them to manage their health. "If the numbers are off, it could lead to confusion, overtraining, or even missed health warnings," Choe cautions. This underlines the necessity for health professionals to educate patients on the variability of wearable tech data, ensuring they remain informed participants in their health journey.

The Road Ahead for Wearable Tech

As technology continues to evolve, improvements in accuracy are encouraging. The researchers noted a trend of gradual enhancements with newer Apple Watch models. This signals potential advancements on the horizon for wearable IT solutions aimed at health management. However, Kang and Choe maintain that while wearables serve to motivate users, they should not supplant professional medical judgment. Rather, it is prudent for practitioners to advocate for these tools as aids rather than absolute metrics in fitness calculations.

Common Misconceptions: What Patients Need to Know

A significant myth surrounding wearable devices is that they are foolproof. Many users assume that the calorie counts and heart rates are unerring, which isn’t the case according to the findings of the Ole Miss study. Health practitioners can advocate that wearables are best viewed as general guides that complement physical activity rather than definitive sources of truth.

Future of Wearables in Healthcare

Looking ahead, the healthcare industry might see more integration of wearable technology within clinical settings. With real-time data available, doctors could potentially use this information as a resource to drive discussions around health and wellness for their patients. However, they must remain aware of the limitations and ensure that different forms of data—from wearables to comprehensive clinical assessments—are considered for effective and safe patient care.

As concierge practitioners, staying attuned to developments in wearable technology will allow you to guide your patients appropriately. By providing them with context on the data from these devices, you can support informed decision-making that emphasizes an active lifestyle balanced with appropriate medical oversight.

Call to Action: Educate and Engage

To harness the benefits of wearable technology effectively, it's essential that health practitioners engage in ongoing education regarding these tools. Share this knowledge with your patients and colleagues to promote a well-rounded understanding of wearable tech as a valuable, albeit imperfect, partner in their health journeys.


Tech Advantage

Write A Comment

*
*
Related Posts All Posts
06.06.2025

Why Healthcare Cybersecurity Remains a Low Priority and What You Can Do

Explore the growing threats in healthcare cybersecurity and how to ensure patient safety with proactive measures.

06.06.2025

Breaking Ground: Cancers Detected Years Early Through Blood Testing

Update How Early Detection Revolutionizes Cancer TreatmentRecent studies have revealed that genetic material shed by tumors can be detected in the bloodstream up to three years before a formal cancer diagnosis. This groundbreaking finding has been established by researchers at the Ludwig Center and Johns Hopkins University, suggesting a new frontier in cancer screening. With such early detection, treatment options increase significantly, enabling early interventions when tumors are less advanced and more likely to be curable.Implications for Patient ManagementThe study highlights the promise of multicancer early detection (MCED) tests using advanced sequencing techniques. Dr. Yuxuan Wang, who led the study, indicated that identifying cancer through blood samples presents an opportunity for healthcare practitioners to manage patients more effectively. As these tests demonstrate capability in detecting tumors years before any symptoms arise, practitioners can initiate preventive measures and tailored treatments at earlier stages.Understanding the Study: Key FindingsIn this longitudinal research following the Atherosclerosis Risk in Communities (ARIC) study participants, the team analyzed plasma samples from 52 individuals—26 diagnosed with cancer shortly after blood sample collection and 26 who were not. Results presented that eight participants, when tested for MCED, successfully yielded positive results up to 3.5 years prior to their formal diagnosis. This level of sensitivity not only affirms the abilities of modern diagnostic technologies but establishes a new paradigm for cancer detection and intervention.The Science Behind MCED TestingThe technology behind multicancer early detection tests involves extracting cell-free DNA from plasma samples, which represents genetic material from multiple smartphone-sized tumors. This approach offers insights into the patient’s health by identifying tumor-derived mutations long before they become clinically significant. As Dr. Bert Vogelstein pointed out, these MCED tests can now serve as a benchmark for effectively increasing the chances of successful cancer management.Potential Challenges and Future Research DirectionsWhile the findings are promising, it is important for practitioners to navigate the implications cautiously. The study emphasizes the necessity of appropriate clinical follow-up after patients receive positive MCED test results. Furthermore, as awareness grows, it raises pivotal discussions about ethics, cost-effectiveness, and accessibility of these cutting-edge screenings. Ongoing research will need to address the operational challenges and ensure that these technologies are integrated equitably across healthcare settings.Why This Matters to Health PractitionersFor concierge health practitioners, keeping abreast of such revolutionary techniques is vital not only for enhancing practice capabilities but also for improving patient outcomes. As healthcare continues to evolve toward more personalized medicine, the importance of being informed on such developments cannot be overstated. This knowledge allows practitioners to propose more proactive healthcare strategies, connecting patients with the most advanced screening technologies available.Conclusion: Taking Action NowWith advancements in early cancer detection, it is crucial for health practitioners to leverage such innovations to strengthen patient relationships and care. Understanding these developments paves the way for improved screening and intervention strategies that can enhance the longevity and quality of life for patients. As we witness the shift towards a future where early diagnostics revolutionize cancer management, practitioners should embrace ongoing education and stay informed about these trends that could profoundly impact their practice.

06.06.2025

FDA Approves Unique Eye Implant to Slow Vision Loss in MacTel Patients

Update Revolutionary Eye Implant Offers Hope for MacTel PatientsIn a groundbreaking development for those affected by macular telangiectasia type 2 (MacTel), the FDA has approved a first-of-its-kind eye implant, ENCELTO, designed to decelerate vision loss associated with this rare retinal disease. For years, those diagnosed with MacTel faced a bleak future with no approved treatments available to halt their degenerative condition, which deteriorates the central part of the retina—crucial for detailed vision.The device, which delivers ciliary neurotrophic factor (CNTF), acts as a neuroprotectant, preserving vital photoreceptor cells from damage. With its origins rooted in collaborative research between Scripps Research Institute and Neurotech Pharmaceuticals, ENCELTO represents a notable milestone in the advancement of therapies for neurodegenerative diseases.The Science Behind ENCELTO: How It WorksENCELTO is not merely a device; it’s a breakthrough in the treatment paradigm for MacTel. By continuously releasing CNTF, it offers a steady level of neuroprotection to retinal cells, potentially delaying the progression of vision loss. According to Dr. Martin Friedlander, a key figure in the development of this implant, CNTF plays a significant role in the health of nerve cells. The ongoing clinical studies suggest that even when the implant is removed—some after as long as 14.5 years—the CNTF effect remains potent, showing promise for long-term efficacy.Clinical Trials: Evidence of EffectivenessThe FDA's endorsement followed two phase 3 clinical studies, which demonstrated that ENCELTO effectively slowed the disappearance of light-sensitive retinal cells over a 24-month period. This is a significant finding for a disease that typically has no viable treatment options. The impressive results from these studies prompted excitement among healthcare practitioners, indicating ENCELTO may transform how we approach treatment for patients suffering from MacTel.Significance for Concierge Health PractitionersFor concierge health practitioners, keeping abreast of novel treatment options like ENCELTO is imperative. Patients with MacTel can experience profound impacts on their daily lives due to the condition. Practitioners need to advocate for these patients, guiding them through available treatment options and managing their expectations. Additionally, as the device becomes available in mid-2025, practitioners must prepare their practices and patient education materials to incorporate this revolutionary treatment.Looking Ahead: Future ImplicationsThe approval of ENCELTO opens new doors not only for individuals with MacTel but also for those suffering from other neurodegenerative diseases. This device exemplifies the innovative potential within biomedicine achieved through robust scientific collaboration. Dr. Friedlander’s optimism suggests we may witness more treatments harnessing the power of engineered cell therapies. This might eventually lead to a broad spectrum of therapeutic devices capable of addressing the neurodegenerative landscape.Practical Insights: What This Means for Your PracticeAs this novel device transitions from clinical trials to real-world applications, here are a few insights for concierge practitioners:Stay Informed: Follow developments as the product releases in June 2025. Attending seminars or webinars hosted by industry experts could provide key updates.Patient Education: Prepare material that explains ENCELTO’s mechanism, benefits, and what patients can expect during and after treatment.Collaborative Care: Coordinate with retina specialists to ensure a holistic approach in patient management integrating the implant and regular eye care.Embracing Innovation: A Call to ActionAs healthcare practitioners, you are at the frontlines of delivering cutting-edge solutions to patients. With the approval of ENCELTO and its innovative approach to treating MacTel, embrace this opportunity to educate yourselves and your patients about this promising treatment. Keeping pace with advancements in medical technology empowers your practice and enhances the quality of care you provide.This isn't just about an exciting new treatment; it's about improving lives and preserving vision for your patients. Stay vigilant, stay informed, and prepare your practice to adapt.

Add Row
Add Element
cropper
update
MYBRANDINGLOGO
Concierge Health Hub logo
update

Concierge Health Hub is a popular free resource for concierge medical practices in the English-speaking world, providing insights into everything from connecting with your patients, to marketing, to regulatory rules.

  • Concierge Health Hub Facebook Page URL
    update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

NEED TO CONTACT US?

If you have any enquiries, contact us now and we will get back to you as soon as possible.

Setup Your Button

   CONTACT US   

{"name":"Contact Us","action_type":"2","optin_action_type":"5","form_redirect_type":"2","form_redirect_custom_url":"","order_form_settings":{"containers":[{"id":"personal-info-wrapper","visible":true,"label":{"id":"of-personal-title","visible":true},"fields":[{"id":"of-full-name","setting":false,"placeholder":"Full Name"},{"id":"of-field-email","setting":false,"placeholder":"Email Address"},{"id":"of-phone-number","setting":true,"visible":false,"require":true,"placeholder":"Enter Your Mobile Phone","additional":{"sms_permission":0}},{"id":"of-gdpr-optin-approval","label":"I Accept To Receive Additional Info","placeholder":"","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"gdpr_optin_approval":"1"}}]},{"id":"shipping-information-wrapper","visible":false,"label":{"id":"of-shipping-title","visible":true},"fields":[{"id":"of-shipping-address","setting":false,"placeholder":"Address"},{"id":"of-shipping-city","setting":false,"placeholder":"City"},{"id":"of-shipping-state","setting":false,"placeholder":"State"},{"id":"of-shipping-zipcode","setting":false,"placeholder":"Postal Code"}]},{"id":"profit-bump-wrapper","visible":true,"otoBgColor":"rgba(219,229,239,1)","otoBorderColor":"rgba(38,71,102,1)","otoTitleBgColor":"rgba(45,78,108,1)","otoArrowsColor":"rgba(255,177,58,1)","fields":[]},{"id":"order-summary-wrapper","visible":true,"orderDynamicBgColor":"rgba(242,242,242,1)","orderDynamicTexColor":"rgba(51,51,51,1)","fields":[]}]},"optin_type":{"showLabels":0,"fields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"fields_labels","label":"","placeholder":"","icon":"","required":0,"visible":1,"system":1,"additional":{}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}},{"name":"gdpr_optin_approval","label":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8=","placeholder":"","icon":"fa-mobile","required":0,"visible":1,"system":1,"additional":{"gdpr_optin_approval":"1","sms_permission":0}}],"customFields":[],"sortedFields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}}],"design":{"form_background_color":"rgb(245, 245, 245)","field_stroke":{"size":"1","color":"rgb(220, 220, 220)"},"field_icons":1,"button_color":"rgb(255, 158, 0)","button_stroke":{"size":"0","color":"rgba(255, 255, 255, 0.2)"},"button_box_shadow_color":"none","field_size":"small","label_size":"16","label_color":"rgb(0, 0, 0)","input_color":"rgb(52, 152, 219)","control_text_color":"rgb(0, 0, 0)","control_text_size":"15"},"mappedFields":[]},"redirect_type":{"url":"","target":0},"next_step":{},"click_to_email":{"value":"info@banidadigital.com"},"click_to_call":{"value":""},"jump_to_block":{},"content":{"header_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyNHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxLjRlbTsiPldlIEFyZSBFeGNpdGVkITwvc3Bhbj48L3NwYW4+","content_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZTo0OHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDowLjllbTsiPjxzdHJvbmc+UExFQVNFIEZJTEwgT1VUIFlPVVIgSU5GTyAgQkVMT1cgVE8gU1VCU0NSSUJFPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","button_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyN3B4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxZW07Ij48c3Ryb25nPlNFQ1VSRSBNWSBTUE9UPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","spam_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuMmVtOyI+V2UgaGF0ZSBTUEFNIGFuZCBwcm9taXNlIHRvIGtlZXAgeW91ciBlbWFpbCBhZGRyZXNzIHNhZmU8L3NwYW4+","sms_text":"UmVjZWl2ZSBTTVMgVGV4dCBVcGRhdGVzIC0gPHNwYW4+b3B0aW9uYWw8L3NwYW4+","sms_text2":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8="},"email_confirmation":{"enable":1,"subject":"V2UgQXJlIEV4Y2l0ZWQhIFlvdXIgSW4h","message":""},"integrations":[],"automation_enable":0,"thank_you":{"type":"popup","redirect_url":"","popup_options":{"background_color":"#ffffff","headline_visible":1,"icon_visible":1,"icon_url":"//my.funnelpages.com/assets-pb/images/thankyou-popup-icon.png","subheadline_visible":1,"button_visible":1,"button_color":"#ffa800","headline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+VGhhbmsgWW91IEZvciBDb250YWN0aW5nIFVzPC9zcGFuPg==","subeadline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+UGxlYXNlIENoZWNrIFlvdXIgRW1haWw8YnIgLz5XZSBXaWxsIEJlIEZvbGxvd2luZyBVcCBTaG9ydGx5PC9zcGFuPg==","button_text":"Q2xvc2U="}}}
Add Element

© 2025 Alicorn Ventures, LLC All Rights Reserved. 30 N. Gould Ste R, Sheridan, WY 82801 . Contact Us . Terms of Service . Privacy Policy

{"company":"Alicorn Ventures, LLC","address":"30 N. Gould Ste R","city":"Sheridan","state":"WY","zip":"82801","email":"info@banidadigital.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*